Geron CorporationMenlo Park, CA United States
Company Description
Geron is working to get important things into our thick heads -- more specifically, it is developing a compound able to penetrate the blood-brain barrier that otherwise keeps potentially valuable drugs out of the brain. The company's research and development is targeting viable therapies for cancer, injury, and degenerative diseases. One of the company's lead products in clinical trials is an hESC therapy (derived from human stem cells) called GRNOPC1 for spinal cord injury. Geron is also focused on anticancer drug candidate GRN163L, which inhibits telomerase, an enzyme that enables cancer cells to replicate indefinitely. Founded in 1992, Geron maintains facilities in California and Scotland.
| 230 Constitution Dr. | Phone: 650-473-7700 | http://www.geron.com |
| Menlo Park, CA 94025 | Fax: 650-473-7750 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Geron Corporation Rankings
| Russell 2000 (June 2011) |
Executives
| 31 executives listed for Geron Corporation's Menlo Park, CA location. | ||
| Chairman | Hoyoung Huh | |
|---|---|---|
| President, Interim CEO, CFO, and Director | David Greenwood | |
| SVP and Chief Scientific Officer, Cell Therapies | Jane Lebkowski | |
Financials
| Company Type | Public - NASDAQ: GERN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 178 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Geron Corporation now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
